| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4023985 | Journal Français d'Ophtalmologie | 2012 | 10 Pages |
Abstract
These results demonstrate efficacy, stability and safety of the ICL V4 phakic IOL for the correction of high ametropia. Long-term follow-up did not show a significant increase in cataract formation in implanted eyes.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
M. Le Loir, B. Cochener,